DS STAGE I MULTIPLE MYELOMA
Clinical trials for DS STAGE I MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new DS STAGE I MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for DS STAGE I MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise in multiple myeloma battle
Disease control OngoingThis phase 3 trial compares two drug combinations for people with newly diagnosed multiple myeloma who are not planning an immediate stem cell transplant. One group gets lenalidomide plus low-dose dexamethasone, and the other gets those two drugs plus bortezomib. The goal is to s…
Matched conditions: DS STAGE I MULTIPLE MYELOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 05:08 UTC
-
Can a pill keep myeloma at bay after transplant? major trial seeks answers
Disease control OngoingThis study looked at whether taking lenalidomide (a drug that helps the immune system fight cancer) after a stem cell transplant can keep multiple myeloma from coming back longer than taking a placebo. About 460 people with active multiple myeloma took part. The goal was to see h…
Matched conditions: DS STAGE I MULTIPLE MYELOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New combo therapy shows promise in myeloma battle
Disease control OngoingThis study tested two different doses of dexamethasone (a chemotherapy drug) combined with lenalidomide (an immune-boosting drug) in 452 people newly diagnosed with multiple myeloma. The goal was to see which dose worked better at shrinking tumors. If the first combination didn't…
Matched conditions: DS STAGE I MULTIPLE MYELOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 01, 2026 15:58 UTC